922 / 1195
ICRU on Adaptive RT
GTV-T (CT, 0Gy)
CTV-T+N (MRI-T2, 0Gy)
GTV-T (CBCT, 30Gy)
Developments in coming years will
hopefully indicate which outcomes
might benefit from 4D treatment
planning and adaptive changes.
However, they will dramatically expand
the complexity of tissue delineation
(often called segmentation), absorbed-
dose specification, and dose reporting.